TR201906158T4 - Etken Maddeler ile Farmasötik-Teknolojik Yardımcı Maddeler Arasındaki Etkileşimleri Engellemek Amacıyla Kullanılan Farmasötik Preparatlar İçin Ayırıcı Katmanlar. - Google Patents
Etken Maddeler ile Farmasötik-Teknolojik Yardımcı Maddeler Arasındaki Etkileşimleri Engellemek Amacıyla Kullanılan Farmasötik Preparatlar İçin Ayırıcı Katmanlar. Download PDFInfo
- Publication number
- TR201906158T4 TR201906158T4 TR2019/06158T TR201906158T TR201906158T4 TR 201906158 T4 TR201906158 T4 TR 201906158T4 TR 2019/06158 T TR2019/06158 T TR 2019/06158T TR 201906158 T TR201906158 T TR 201906158T TR 201906158 T4 TR201906158 T4 TR 201906158T4
- Authority
- TR
- Turkey
- Prior art keywords
- layer
- separating
- pharmaceutical
- separating layer
- core
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 230000003993 interaction Effects 0.000 title 1
- ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 abstract 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000001913 cellulose Substances 0.000 abstract 2
- 229960002866 duloxetine Drugs 0.000 abstract 2
- 229960002496 duloxetine hydrochloride Drugs 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 210000004051 gastric juice Anatomy 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- JFTURWWGPMTABQ-UHFFFAOYSA-N n,n-dimethyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine Chemical compound C=1C=CC2=CC=CC=C2C=1OC(CCN(C)C)C1=CC=CS1 JFTURWWGPMTABQ-UHFFFAOYSA-N 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 235000005985 organic acids Nutrition 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Buluş, duloksetin veya bunun farmasötik olarak kabul edilebilir bir tuzunu, özellikle de duloksetin hidroklorür içeren bir etken maddeye sahip bir çekirdeği; çekirdek üzerinde isteğe bağlı olarak bir birinci ayırıcı katmanı; birinci ayırıcı katman üzerinde birinci ayırıcı katmandan farklı ve yine isteğe bağlı olarak sübstitüye edilmiş selülozdan oluşan ve bir ya da birden fazla organik asit içeren bir estere sahip ikinci bir ayırıcı katmanı; birinci ve ikinci ayırıcı katmandan farklı, mide öz suyuna dirençli, (met)akrilik asit içeren bir polimeri kapsayan ve bileşimin dış katmanının oluşturan bir katmanı içeren granüler yapıdaki bir farmasötik preparat ile ilişkilidir. Buluş, duloksetin veya bunun farmasötik olarak kabul edilebilir bir tuzunu, özellikle de duloksetin hidroklorür içeren bir etken maddeye sahip bir çekirdeği; çekirdek üzerinde seçenek olarak bir birinci ayırıcı katmanı; birinci ayırıcı katman üzerinde birinci ayırıcı katmandan farklı ve yine isteğe bağlı olarak sübstitüye edilmiş selülozdan oluşan ve bir ya da birden fazla organik asit içeren bir estere sahip ikinci bir ayırıcı katmanı; birinci ve ikinci ayırıcı katmandan farklı, mide öz suyuna dirençli, (met)akrilik asit içeren bir polimeri kapsayan ve bileşimin dış katmanının oluşturan bir katmanı içeren granüler yapıdaki bir farmasötik preparat ile ilişkilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009033621A DE102009033621A1 (de) | 2009-07-17 | 2009-07-17 | Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201906158T4 true TR201906158T4 (tr) | 2019-05-21 |
Family
ID=42543200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/06158T TR201906158T4 (tr) | 2009-07-17 | 2010-07-16 | Etken Maddeler ile Farmasötik-Teknolojik Yardımcı Maddeler Arasındaki Etkileşimleri Engellemek Amacıyla Kullanılan Farmasötik Preparatlar İçin Ayırıcı Katmanlar. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2453880B1 (tr) |
DE (1) | DE102009033621A1 (tr) |
ES (1) | ES2726049T3 (tr) |
TR (1) | TR201906158T4 (tr) |
WO (1) | WO2011006670A1 (tr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2601841T3 (es) * | 2010-05-25 | 2017-02-16 | Hetero Research Foundation | Composición farmacéutica oral de duloxetina |
HUE036187T2 (hu) | 2012-04-30 | 2018-06-28 | Tillotts Pharma Ag | Késleltetett leadású gyógyszerkészítmény |
CN103393615B (zh) * | 2013-07-24 | 2015-07-15 | 海南华益泰康药业有限公司 | 一种度洛西汀肠溶小丸及其制备方法 |
CA2923063C (en) | 2013-10-29 | 2021-09-07 | Tillotts Pharma Ag | A delayed release drug formulation |
CN104107169A (zh) * | 2014-07-12 | 2014-10-22 | 浙江华海药业股份有限公司 | 一种盐酸度洛西汀药物组合物及其制备方法 |
GB2536936B (en) * | 2015-04-01 | 2018-10-31 | Jaguar Land Rover Ltd | Damper |
JP6866136B2 (ja) * | 2016-11-30 | 2021-04-28 | 共和薬品工業株式会社 | デュロキセチン塩酸塩を含む口腔内崩壊錠 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH27186A (en) | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
US5508276A (en) | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
JP2008543929A (ja) * | 2005-06-20 | 2008-12-04 | カディラ・ヘルスケア・リミテッド | デュロキセチンの調節放出型の投与製剤 |
US20090068263A1 (en) * | 2006-04-20 | 2009-03-12 | Themis Laboratories Private Limited | Multiple unit compositions |
WO2007139886A2 (en) | 2006-05-22 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Duloxetine hydrochloride delayed release formulations |
BRPI0720958A2 (pt) * | 2006-12-27 | 2014-03-18 | Lek Pharmaceuticals | Omposição de duloxetina |
US20080226711A1 (en) * | 2007-03-12 | 2008-09-18 | Torrent Pharmaceuticals Ltd. | Pharmaceutical compositions of duloxetine |
CL2008002032A1 (es) | 2007-07-13 | 2009-01-23 | Synthon Bv | Forma de dosis farmaceutica que posee una pluralidad de pellets, cada pellet comprende, un nucleo de pellet con un diametro de 600 a 1000 micrometros, capa de farmaco que comprende duloxetina o una sal y aglutinante de preferencia metil celulosa, una capa de separacion y una capa de recubrimiento enterico; proceso de preparacion |
-
2009
- 2009-07-17 DE DE102009033621A patent/DE102009033621A1/de not_active Withdrawn
-
2010
- 2010-07-16 WO PCT/EP2010/004362 patent/WO2011006670A1/de active Application Filing
- 2010-07-16 TR TR2019/06158T patent/TR201906158T4/tr unknown
- 2010-07-16 EP EP10734458.2A patent/EP2453880B1/de active Active
- 2010-07-16 ES ES10734458T patent/ES2726049T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
DE102009033621A1 (de) | 2011-01-20 |
EP2453880A1 (de) | 2012-05-23 |
WO2011006670A1 (de) | 2011-01-20 |
ES2726049T3 (es) | 2019-10-01 |
EP2453880B1 (de) | 2019-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201906158T4 (tr) | Etken Maddeler ile Farmasötik-Teknolojik Yardımcı Maddeler Arasındaki Etkileşimleri Engellemek Amacıyla Kullanılan Farmasötik Preparatlar İçin Ayırıcı Katmanlar. | |
EA201071054A1 (ru) | Твердый препарат, растворяющийся во рту | |
EA201491783A1 (ru) | Лекарственный препарат с отсроченным высвобождением | |
JP2010535814A5 (tr) | ||
WO2011039768A3 (en) | Pharmaceutical compositions for reducing alcohol-induced dose dumping | |
WO2008132712A3 (en) | Combination pharmaceutical compositions | |
AU2007247480A8 (en) | Pharmaceutical combination comprising 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and an NSAID | |
MX2010010647A (es) | Proceso para preparar formulaciones de dabigatran para administracion oral. | |
MX352326B (es) | Tableta resistente al alcohol. | |
JP2011137005A5 (tr) | ||
EA201071218A1 (ru) | Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью | |
BRPI0908942A2 (pt) | Sistemas de distribuição de fármacos compreendendo fármacos fracamente básicos e ácidos orgânicos | |
WO2011101866A3 (en) | Gastric retention formulation containing baclofen | |
EA200800666A1 (ru) | Фармацевтическая композиция с контролируемым высвобождением, содержащая карведилол | |
WO2012002640A3 (ko) | 도네페질을 함유하는 경피흡수제제 | |
WO2010122583A3 (en) | Oral pharmaceutical compositions of acid labile substances | |
WO2011140446A3 (en) | Pharmaceutical formulations | |
WO2012092486A3 (en) | Modified release benzimidazole formulations | |
PE20110943A1 (es) | Formulacion oral solida de alisquireno | |
WO2009120389A8 (en) | Oral and injectable formulations of tetracycline compounds | |
WO2007097888A3 (en) | Fluoroquinolone carboxylic acid salt compositions | |
AR061165A1 (es) | Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas | |
BR112015004091A2 (pt) | formulação de cápsula de compósito farmacêutico que compreende irbesartan e inibidor de hmg-coa redutase | |
CL2013003176A1 (es) | Formulacion farmaceutica oral de liberacion sostenida que comprende dos tabletas que contienen 1000 mg de paracetamol, el cual esta presente en una capa de liberacion sostenida y otra de liberacion inmediata, en una proporcion de paracetamol por capa de 80-90 %: 10-20 %, donde la dosis unitaria comprende 2000 mg de paracetamol. | |
WO2013062902A3 (en) | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with atorvastatin |